UROLINQ Referral Management Policy Purpose To ensure timely, professional, and coordinated care for patients referred to UROLINQ by other healthcare providers, while maintaining clear communication, confidentiality, and clinical accountability. 1. Referral Acceptance Criteria •UROLINQ accepts referrals from licensed doctors, nurse practitioners, physician assistants, and allied health professionals. •Referrals must be for non-emergency urological evaluations suitable for telemedicine (e.g., LUTS, haematuria workup, post-op follow-up, device consultations). •Complex cases requiring in-person evaluation may be re-directed with appropriate recommendations. 2. Referral Submission Process •Referrals must be submitted via: oSecure referral form on the UROLINQ website. oEncrypted email or fax (details provided on our website). oDirect EMR-to-EMR communication (where integration is available). •Required documentation: oPatient demographics and contact information. oReason for referral and clinical question(s). oRelevant medical history, labs, imaging, and medications. oReferring provider's contact information. 3. Triage and Scheduling •All referrals are reviewed within 2 – 14 business days by the UROLINQ clinical team. •Triage categories: oRoutine: review within 7–14 days. oUrgent: review within 2–5 days (based on clinician availability). oVery Urgent: Care Provider is encouraged to place an urgent audio call to the Urolinq clinic •Patients may also be encouraged to contact UROLINQ directly by to scheduling a virtual appointment. 4. Communication and Updates •Confirmation of referral receipt is sent to the referring care provider. •Post-consultation, a summary report including findings, assessment, and management plan will be securely sent within 48 hours of the review. •For ongoing shared care, UROLINQ will maintain collaborative communication with the referring care provider. 5. Continuity of Care •Patients remain under the care of their primary/referring provider unless otherwise agreed. •UROLINQ can assist with further specialist referrals, imaging, or lab coordination as needed. •In-person follow-up needs will be referred to our clinic or to trusted local urologists or tertiary care centres. 6. Data Privacy & Consent •All patient information is handled in compliance with applicable privacy regulations (e.g., HIPAA). •Patients who require direct consultation with the Urolinq specialist must provide informed consent for telehealth services and data sharing prior to their consultation. 7. Feedback and Quality Assurance •Referring providers are invited to provide feedback to continuously improve referral pathways. •UROLINQ conducts regular audits of referral timelines, clinical outcomes, and communication metrics.